Private Equity Eyes Swiss Drug Distribution Market
Private equity is shifting towards Swiss drug distribution investments.
Tag: private-equity
TPG Faces $600 Million Loss from Cosmetics Investment
TPG’s $600 million loss reveals risks in cosmetics investments.
Utah’s $500 Million Investment Marks a New Era for Private Equity
Utah’s investment signifies a new era in private equity.